Well, several financial statements have been issues lately. And yep, TILT was one of them. Which, I had a scan through this morning and simply ‘noped’ right on past them. At this point (with rest read more
Well, several financial statements have been issues lately. And yep, TILT was one of them. Which, I had a sca read more
Ever since Cyto and I toured Cronos in January 2018 we have said “they are playing a different game”. This continues to be their game plan with the phrase “asset light” approach repeate read more
Ever since Cyto and I toured Cronos in January 2018 we have said “they are playing a different game”.&nbs read more
Open up the MDA and Fins and following along. I note that there is very little stratification of medical versus adult rec in the MDA. Which makes it hard to see if they are going backwards o read more
Open up the MDA and Fins and following along. I note that there is very little stratification of medical v read more
Nice to see the other analysts are catching on to the Finished Goods and throughput issues we have been talking about since mid-February. Cronos started the present Q with far lesser Finished read more
Nice to see the other analysts are catching on to the Finished Goods and throughput issues we have been talki read more
Cronos, much like Tilray, didn’t give a lot of color in Fins and MDA about Medical versus Rec results nor QoQ changes. Open up the fins and MDA and follow along. Sales: Sales net of Excis read more
Cronos, much like Tilray, didn’t give a lot of color in Fins and MDA about Medical versus Rec results nor Q read more
I used this graph in "Hexo in Pictures" post, but in case you skipped it because you are not interested in Hexo... I thought I would re-post. I will be posting Trend Analysis per LP against these me read more
I used this graph in "Hexo in Pictures" post, but in case you skipped it because you are not interested in He read more